Diligence memo · auto-generated · as of July 2, 2026
Niche Biopharmaceuticals LLC
Niche Biopharmaceuticals LLC looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Niche Biopharmaceuticals LLC operates in Pharmaceuticals, based in SHOREWOOD.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Niche Biopharmaceuticals LLC has raised $300K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $200K on 2023-01-20.
Most recent recorded round closed around 2025-04-30.
Valuation (modeled)modeled
Provath models Niche Biopharmaceuticals LLC at approximately $278K (range $56K–$729K). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.19× the median modeled value of Pre-Seed Pharmaceuticals companies in 2025–2027 (19 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 27 months.
Last raise 14 mo ago; this sector typically re-raises about every 13 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 2.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 8% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 0% of those peers.
Closest niche peers: Fedora Pharmaceuticals Inc., PRG FlowChem, Inc., Adora Animal Health Corp, ABLi Therapeutics, Inc., NextEvo, Inc..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.